StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Medicenna Therapeutics's total assets was C$36.45M at Mar 31, 2023. For fiscal 2023 it was C$36.45M, up 55.4% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2023Mar 31, 2023C$36.45M+55.4%
FY2022Mar 31, 2022C$23.46M-44.5%
FY2021Mar 31, 2021C$42.25M+11.2%
FY2020Mar 31, 2020C$38.00M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ1 2023Mar 31, 2023C$36.45M–
Q4 FY2022CQ1 2022Mar 31, 2022C$23.46M–
Q4 FY2021CQ1 2021Mar 31, 2021C$42.25M–
Q4 FY2020CQ1 2020Mar 31, 2020C$38.00M–

More Medicenna Therapeutics figures

See a number that looks wrong?